EUCTR2009-016240-40-GR进行中（未招募）不适用
MULTICENTER, RANDOMIZED, DOUBLE-BLIND, COMPARATIVE WITH THE REFERENCE PRODUCT CLINICAL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF THE THERAPY WITH THE COMBINATION OF BENZOYL PEROXIDE-ERYTHROMYCIN/VERISFIELD, GEL, (5+3)% W/W FOR THE TOPICAL TREATMENT OF ACNE VULGARIS
VERISFIELD (UK) LTD, GREEK BRANCH0 个研究点开始时间: 2010年4月16日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- PATIENTS WITH MILD TO MODERATE ACNE VULGARIS
- •- MALE AND FEMALE PATIENTS AGED 12-35 YEARS
- •- MALES AND FEMALES WHO ARE CONSIDERED HEALTHY
- •- FEMALE PATIENTS WHO DO NOT SHOW ANY SIGNS OF HYPERANDROG?NISM
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- PATIENTS WHO HAVE PARTICIPATED OR CURRENTLY PARTICIPATING TO ANOTHER STUDY
- •- PATIENTS ON TOPICAL OR SYSTEMIC TREATMENT FOR ACNE VULGARIS
- •- PATIENTS WHO RECEIVE DRUGS THAT MIGHT INFLUENCE THE FINDINGS OF THE STUDY
- •- PATIENTS WITH CARDIOVASCULAR, NEOPLASMATIC, HAEMATOLOGICAL, HEPATIC, NEUROLOGICAL, RENAL, ENDOCRINE AND GASTROENTEROLOGICAL DISEASE
- •- PATIENTS WITH A DERMATOLOGICAL LESION IN THE AREA (OR IN CLOSE PROXIMITY e.g. 3cm) TO BE TREATED
- •- PREGNANT OR LACTATING PATIENTS
- •- FEMALE PATIENTS IN REPRODUCTIVE AGE WHO DO NOT USE ADEQUATE CONTRACEPTION
研究者
相似试验
已完成
不适用
COMPARATIVE, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-MASKED STUDY OF AZITROMYCIN SR VERSUS LEVOFLOXACIN FOR THE TREATMENT OF PNEUMONIA ACQUIRED IN THE MILD TO MODERATE COMMUNITY IN ADULTS-J159 Bacterial pneumonia, unspecifiedBacterial pneumonia, unspecifiedJ159PER-023-03PFIZER S.A.,
已完成
不适用
COMPARATIVE, MULTICENTER, DOUBLE-BLIND, RANDOMIZED STUDY OF RIFAXIMIN VS CYPROFLOXACIN (CIPRO®) IN THE TREATMENT OF DISEASE DIAPEREA CAUSED BY ENTEROPATHOGENIC ORGANISMS-A04 Other bacterial intestinal infectionsOther bacterial intestinal infectionsA04PER-055-02IVERSIDAD PERUANA CAYETANO HEREDIA,
进行中（未招募）
不适用
MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARATIVE WITH THE REFERENCE PRODUCT CLINICAL STUDY TO DEMONSTRATE THE SAFETY AND EFFICACY OF THE THERAPY WITH THE COMBINATION ERYTHROMYCIN-ISOTRETINOIN/VERISFIELD, GEL, (2.0+0.05)% W/W FOR THE TOPICAL TREATMENT OF MILD TO MODERATE ACNEEUCTR2009-016241-25-GRVERISFIELD (UK) LTD, GREEK BRANCH
进行中（未招募）
不适用
MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARATIVE STUDY WITH THE REFERENCE PRODUCTS, FOR ASSESSMENT OF THERAPEUTIC SUPERIORITY OF THE COMBINATION CLINDAMYCIN-TRETINOIN/VERISFIELD, GEL, (1.0+0.025)%, (VERSUS THE MONOTHERAPY WITH CLINDAMYCIN OR TRETINOIN) FOR THE TOPICAL TREATMENT OF ACNEACNE (ACNE VULGARIS)EUCTR2009-017201-11-GRVERISFIELD (UK) LTD, GREEK BRANCH
进行中（未招募）
不适用
MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, TWO-ARM PARALLEL GROUPS STUDY DESIGN TO DEMONSTRATE THE EFFICACY AND TOLERABILITY OF A SINGLE DOSE OF BDP SUSPENSION FOR NEBULISATION 1600 mcg VS PLACEBO IN THE TREATMENT OF CHILDREN AGED 6 MONTHS TO 3 YEARS WITH A CLINICAL DIAGNOSIS OF MODERATE CROUP - NDEUCTR2009-014376-22-ITCHIESI